Opko Health, Inc.

311 articles about Opko Health, Inc.

• Three Drugmakers Facing FDA Decisions This Quarter

  3/10/2016

• Opko Health's GeneDx Recognizes International Rare Disease Day With Donation Of Free Exome Tests To Syndromes Without A Name

  2/29/2016

• Opko Health's GeneDx Participating In The Molecular Medicine Tri-Conference 2016 In San Francisco

  2/24/2016

• Opko Health To Announce 2015 Fourth Quarter And Full Year Financial Results On February 29, 2016

  2/23/2016

• Opko Health Announces Dosing Of First Patient In Phase IIa Clinical Study Of A Long-Acting Factor Viia For The Treatment Of Hemophilia

  2/23/2016

• Opko Health Acquires Interest In Xenetic Biosciences

  2/12/2016

• Opko Health’s GeneDx To Present At Personalized Medicine World Conference

  1/22/2016

• Opko Health’s GeneDx Study Of More Than 10,000 Individuals Tested With Multigene NGS Hereditary Cancer Panel Reveals New Risks

  12/21/2015

• Opko Health’s GeneDx Study Demonstrates Whole Exome Sequencing Usefulness In Diagnosing Rare Disorders

  12/9/2015

• Opko Health To Present At The Jefferies Autumn 2015 Global Healthcare Conference

  11/18/2015

• Opko Health Licensee Tesaro Announces The Launch Of VARUBI(TM) (Rolapitant) In The United States

  11/16/2015

• Opko Health 4Kscore Test Receives Category I CPT Code Approval

  11/12/2015

• Opko Health Announces Third Quarter Financial And Operating Results

  11/10/2015

• Opko Health To Announce Third Quarter Operating And Financial Results On November 9, 2015

  11/6/2015

• Vanderbilt University School of Medicine And Opko Health Collaborate On Genomics

  10/13/2015

• Opko Health Presents Clinical Data On Its Long-Acting Human Growth Hormone (hGH-CTP) In Two Oral Presentations At The 54th Annual Meeting Of The European Society For Pediatric Endocrinology (ESPE)

  10/7/2015

• Insider Buying: Opko Health CEO Acquires $420,768.00 in Stock

  9/28/2015

• Opko Health To Present At The Ladenburg Thalmann 2015 Healthcare Conference

  9/22/2015

• Opko Health Announces Global License Agreement For The Discovery Of Novel Antimicrobials

  9/9/2015

• Opko Health To Be Present At The Barrington Research Fall Investment Conference

  8/26/2015